换一批
换一批Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
作者：
Megan R W,Barber [1]
;
Manuel Francisco,Ugarte-Gil [2]
;
John G,Hanly [3]
;
Murray B,Urowitz [4]
;
Yvan,St-Pierre [5]
;
Caroline,Gordon [6]
;
Sang-Cheol,Bae [7]
;
Juanita,Romero-Diaz [8]
;
Jorge,Sanchez-Guerrero [9]
;
Sasha,Bernatsky [5]
;
Daniel J,Wallace [10]
;
David A,Isenberg [11]
;
Anisur,Rahman [11]
;
Joan T,Merrill [12]
;
Paul R,Fortin [13]
;
Dafna D,Gladman [14]
;
Ian N,Bruce [15]
;
Michelle,Petri [16]
;
Ellen M,Ginzler [17]
;
Mary Anne,Dooley [18]
;
Rosalind,Ramsey-Goldman [19]
;
Susan,Manzi [20]
;
Andreas,Jönsen [21]
;
Ronald F,van Vollenhoven [22]
;
Cynthia,Aranow [23]
;
Meggan,Mackay [24]
;
Guillermo,Ruiz-Irastorza [25]
;
S Sam,Lim [26]
;
Murat,Inanc [27]
;
Kenneth C,Kalunian [28]
;
Søren,Jacobsen [29]
;
Christine A,Peschken [30]
;
Diane L,Kamen [31]
;
Anca,Askanase [32]
;
Bernardo A,Pons-Estel [33]
;
Francesca S,Cardwell [34]
;
Graciela S,Alarcón [35]
;
Ann E,Clarke [36]
作者单位：
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
[1]
Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, Peru.;Rheumatology, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
[2]
Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.;Dalhousie University, Halifax, Nova Scotia, Canada.
[3]
Lupus Program, Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.;Krembil Research Institute, Toronto, Ontario, Canada.
[4]
Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
[5]
Rheumatology Research Group, Birmingham University Medical School, Birmingham, UK.
[6]
Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea (the Republic of).;Hanyang Institute of Bioscience and Biotechnology, Seoul, Korea (the Republic of).
[7]
Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico.
[8]
University Health Network, Toronto, Ontario, Canada.;Mount Sinai Hospital, Toronto, Ontario, Canada.
[9]
Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
[10]
Centre for Rheumatology, Department of Medicine, University College London, London, UK.
[11]
Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
[12]
Centre ARThrite, CHU de Québec, Université Laval, Quebec City, Quebec, Canada.
[13]
Krembil Research Institute, Toronto, Ontario, Canada.;Lupus Program, Centre for Prognosis in The Rheumatic Diseases, University of Toronto, Toronto, Ontario, Canada.
[14]
Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.;The Kellgren Centre for Rheumatology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
[15]
Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
[16]
Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA.
[17]
Thurston Arthritis Research Centre, University of North Carolina, Chapel Hill, North Carolina, USA.
[18]
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
[19]
Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
[20]
Lund University, Clinical Sciences, Lund, Sweden.
[21]
Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, The Netherlands.
[22]
The Feinstein Institute for Medical Research, Manhasset, New York, USA.
[23]
Feinstein Institute for Medical Research, Manhasset, New York, USA.
[24]
Biobizkaia Health Research Institute, Hospital Universitario Cruces, Barakaldo, Spain.
[25]
School of Medicine, Emory University, Atlanta, Georgia, USA.
[26]
Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Medical Faculty, Capa, Istanbul, Turkey.
[27]
University of California School of Medicine, La Jolla, California, USA.
[28]
Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.
[29]
University of Manitoba, Winnipeg, Manitoba, Canada.
[30]
Medical University of South Carolina, Charleston, South Carolina, USA.
[31]
Division of Rheumatology, Columbia University Lupus Center, Columbia University College of Physicians & Surgeons, New York, New York, USA.
[32]
Grupo Oroño, Centro Regional de Enfermedades Autonmunes y Reumáticas, Rosario, Argentina.
[33]
Geography & Environmental Management, University of Waterloo, Waterloo, Ontario, Canada.
[34]
Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, The University of Alabama, Birmingham, Alabama, USA.
[35]
Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada aeclarke@ucalgary.ca.
[36]
主题词
人类(Humans);女(雌)性(Female);红斑狼疮, 系统性(Lupus Erythematosus, Systemic);缓解诱导(Remission Induction);男(雄)性(Male);成年人(Adult);中年人(Middle Aged);卫生保健费用(Health Care Costs);疾病严重程度指数(Severity of Illness Index);免疫抑制剂(Immunosuppressive Agents);泼尼松(Prednisone);队列研究(Cohort Studies)
DOI
10.1136/ard-2024-225613
PMID
38754981
发布时间
2025-01-21
- 浏览0
Annals of the rheumatic diseases
Annals of the rheumatic diseases
1295-1303页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
